Angiotensin II is involved in the progression of renal disease: Importance of non-hemodynamic mechanisms

Nephrologie

Volumn 19, Issue 7, 1998, Pages 451-456

  Wolf, G ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Angiotensin II; Cell cycle; Glomerulosclerosis; Hypertrophy

Indexed keywords

ANGIOTENSIN; CHEMOKINE; COLLAGEN TYPE 4; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; PROTEIN P27; RANTES; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DISEASE COURSE; ENDOTHELIUM CELL; GLOMERULUS; HYPERTROPHY; KIDNEY DISEASE; KIDNEY TUBULE CELL; MESANGIUM CELL; MITOSIS INHIBITION; NONHUMAN; PROTEIN SYNTHESIS;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; GROWTH SUBSTANCES; HUMANS; IMMUNITY; KIDNEY DISEASES;

EID: 0031733560     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-66.
2. Jacobson HR. Chronic renal failure: Pathophysiology. Lancet 1991; 338: 419-23.
3. Kamper AL, Stradngaard S, Leyssac PP. Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial. Am J Hypertens 1992; 5: 423-30.
4. Maschio G, Alberti D, Janin G, Locatelli F, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-45.
5. The GISEN group. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349: 1857-63.
6. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progresssive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000.
7. Ikoma M, Kawamura T, Kkinuma Y, Fogo A, Ichikawa I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 1991; 40: 195-202.
8. Yoshida Y, Fogo A, Ichikawa I. Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney int 1989; 35: 654-60.
9. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987; 79: 1-6.
10. Wolf G, Neilson EG. Angiotensin II as a renal cytokine. News Physiol Sci 1994; 9: 40-2.
11. Chansel D, Dussaule JC, Ardaillou N, Ardaillou R. Identification and regulation of renin in human cultured mesangial cells. Am J Physiol 1987; 251: F32-F8.
12. Wolf G, Neilson EG. From converting enzyme inhibition to angiotensin II receptor blockade: New insight on angiotensin II receptor subtypes in the kidney. Exp Nephrol 1996: 4 (Suppl. 1): 8-19.
13. Wolf G, Ziyadeh FN. The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 1997; 29: 153-63.
14. Anderson S. Ageing and the renin-amgiotensin systen. Nephrol Dial Transplant 1997; 12: 1093-4.
15. Floege J, Burns MW, Alpers CE, Yoshimura A, et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992; 41: 297-309.
16. Wolf G, Neilson EG. Cellular biology of tubulointerstitial growth. Curr Topics Pathol 1995; 88: 69-97.
17. Lane PH. Furosemide treatment, angiotensin II, and renal growth and development in the rat. Ped Res 1995; 37: 747-54.
18. Kaneto H, Morrissey JJ, McCreaken R, Reyers A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994; 45: 1637-47.
19. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19: 464-74.
20. Wolf G, Haberstroh U, Neilson EG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 1992; 140: 95-107.
21. Anderson PW, Do Ys, Hsueh WA. Angiotensin II causes mesangial cell hypertrophy. Hypertension 1993; 21: 29-35.
22. Wolf G, Neilson EG. Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993; 3: 1531-40.
23. Wolf G. Angiotensin as a renal growth promoting factor, in: Mukhodpadhyay AK, Raizada MK (Eds): Tissue Renin-angiotensin Systems. New York: Plenum Press, 1995, 136-225.
24. Wolf G, Ziyadeh FN, Zahner G, Stahl RAK. Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hypertension 1996; 27: 897-905.
25. Johnson RJ. What mediates progressive glomerulosclerosis? The glomerular endothelium comes of age. Am J Pathol 1997; 151: 1179-81.
26. Norman J, Badie-Dezfooly B, Nord ER Kurtz I, Schlosser J, et al. EGF-induced mitogenesis in proximal tubular cells: Potentiation by angiotensin II. Am J Physiol 1987; 253: F299-F309.
27. Wolf G, Neilson EG. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 1990; 259: F768-F77.
28. 1 receptor. Nephrol Dial Transplant 1993; 8: 128-33.
29. Wolf G. Regulation of renal tubular cell growth: Effects of angiotensin II. Exp Nephrol 1994; 2: 107-14.
30. Wolf G, Neilson EG. Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. Kidney Int 1993; 43 (Suppl. 39): S100-S7.
31. Wolf G, Ziyadeh FN. Renal tubular hypertrophy induced by angiotensin II. Sem Nephrol 1997; 17: 448-54.
32. Kipl. Kidney Int 1996; 50: 2112-9.
33. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 1993; 92: 1366-72.
34. Wolf G, Ziyadeh FN, Helmchen U, Zahner G, et al. ANG II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop. Am J Physiol 1995; 268: F940-F7.
35. Ishidoya S, Morrissey J, McCrakcen R, Klahr S. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 1996; 49: 1110-9.
36. Wolf G. Link between angiotensin II and TGF-β in the kidney. Miner Electrolyte Metab (in press).
37. 1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system. Kidney Int 1997; 51: 1553-67.
38. Lee LK, Meyer TW, Pollock AS, Lovett DH. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 1995; 96: 953-64.
39. Arai M, Isaka Y, Akagi Y, Sugiura T, et al. In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phentypic changes of the mesangial cells and glomerular sclerosis. Biochem Biophys Res Commun 1995; 206: 525-32.
40. 1 receptors. Kidney Int 1994; 45: 177-84.
41. 1 and matrix mRNAs in mesangial cells. Kidney Int 1996; 50: 745-53.
42. Wolf G, Killen PD, Neilson EG. Intracellular signaling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells. Cell Reg 1991; 2: 219-27.
43. Wolf G, Kalluri R, Ziyadeh FN, Stahl RAK. Angiotensin II (A II) stimulates α3 chain of type IV collagen in cultured proximal tubular (MCT) cells. J Am Soc Nephrol 1997; 8 (Abstr.): 410.
44. Ruiz-Ortega M, Egido J. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 1997; 52: 1497-510.
45. Kagami S, Kuhara T, Okada K, Kuroda Y, Border Wa, Noble NA. Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int 1997; 51: 664-71.
46. 1 cells. Nephrol Dial Transplant 1995; 10: 1305-12.
47. Van Goor H, Ding G, Kees-Folts D, Grond J, Schreiner GF, Diamond JR. Biology of disease. Macrophages and renal disease. Lab Invest 1994; 71: 456-64.
48. Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, et al. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest 1997; 100: 1047-58.
49. 1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis. Exp Nephrol (in press).
50. Ardaillou R. Hormones polypeptidiques et insuffisance rénale chronique. Rev Pract 1980; 30: 2563-70.
51. Richet G. From Bright's disease to modern nephrology: Pierre Rayer's innovative method of clinical investigation. Kidney Int 1991; 39: 787-92.